We are live on ! Find out more
FAM

Fred Alger Management Portfolio holdings

AUM $22.8B
1-Year Est. Return 64.63%
This Fund
S&P 500
This Quarter Est. Return
+1.6%
1 Year Est. Return
+64.63%
3 Year Est. Return
+243.99%
5 Year Est. Return
+318.3%
10 Year Est. Return
+1,899.64%
AUM
$18.9B
AUM Growth
-$804M
Cap. Flow
-$821M
Cap. Flow %
-4.34%
Top 10 Hldgs %
35.79%
Holding
598
New
47
Increased
155
Reduced
267
Closed
77

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$149M
2
AGN
Allergan plc
AGN
+$142M
3
BABA icon
Alibaba
BABA
+$110M
4
NWL icon
Newell Brands
NWL
+$108M
5
MDT icon
Medtronic
MDT
+$108M

Top Sells

Rank Stock Value
1
JAH
JARDEN CORPORATION
JAH
+$258M
2
MCD icon
McDonald's
MCD
+$149M
3
META icon
Meta Platforms (Facebook)
META
+$134M
4
AAPL icon
Apple
AAPL
+$134M
5
KR icon
Kroger
KR
+$121M

Sector Composition

Rank Sector Weight
1 Healthcare 20.07%
2 Technology 17.82%
3 Communication Services 17.13%
4 Consumer Discretionary 12.59%
5 Industrials 10.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TBPH icon
401
Theravance Biopharma
TBPH
$874M
$318K ﹤0.01%
+14,000
New +$302K
BAP icon
402
Credicorp
BAP
$30.9B
$307K ﹤0.01%
1,989
-898
-31% -$129K
MMYT icon
403
MakeMyTrip
MMYT
$4.67B
$301K ﹤0.01%
+20,225
New +$338K
HOLX
404
DELISTED
Hologic
HOLX
$294K ﹤0.01%
8,500
-574,193
-99% -$19.9M
GBT
405
DELISTED
Global Blood Therapeutics, Inc.
GBT
$282K ﹤0.01%
+17,000
New +$343K
WEC icon
406
WEC Energy
WEC
$37.7B
$278K ﹤0.01%
4,256
+193
+5% +$11.6K
EVH icon
407
Evolent Health
EVH
$475M
$250K ﹤0.01%
+13,000
New +$179K
ARCT icon
408
Arcturus Therapeutics
ARCT
$157M
$237K ﹤0.01%
7,529
-1,428
-16% -$45K
CLDX icon
409
Celldex Therapeutics
CLDX
$2.77B
$234K ﹤0.01%
3,547
-12,796
-78% -$812K
AVXS
410
DELISTED
AveXis, Inc. Common Stock
AVXS
$228K ﹤0.01%
+6,000
New +$203K
NI icon
411
NiSource
NI
$22.4B
$212K ﹤0.01%
8,000
-2,500
-24% -$60K
CMS icon
412
CMS Energy
CMS
$23.1B
$206K ﹤0.01%
4,500
-1,500
-25% -$63K
GWPH
413
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$206K ﹤0.01%
+2,250
New +$189K
WBMD
414
DELISTED
WebMD Health Corp.
WBMD
$203K ﹤0.01%
3,500
-6,000
-63% -$375K
ITCI
415
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$202K ﹤0.01%
+5,200
New +$187K
RDHL
416
Redhill Biopharma
RDHL
$3.85M
$169K ﹤0.01%
16
FEIC
417
DELISTED
FEI COMPANY
FEIC
$168K ﹤0.01%
1,571
-188,158
-99% -$18M
RGNX icon
418
Regenxbio
RGNX
$623M
$160K ﹤0.01%
20,000
+2,000
+11% +$22.2K
CMRX
419
DELISTED
Chimerix, Inc.
CMRX
$142K ﹤0.01%
36,150
TRV icon
420
Travelers Companies
TRV
$80.8B
$135K ﹤0.01%
1,134
+34
+3% +$3.85K
NOC icon
421
Northrop Grumman
NOC
$77B
$68K ﹤0.01%
304
-28
-8% -$5.89K
IBM icon
422
IBM
IBM
$202B
$59K ﹤0.01%
405
AZO icon
423
AutoZone
AZO
$48.3B
$55K ﹤0.01%
69
CM icon
424
Canadian Imperial Bank of Commerce
CM
$107B
$47K ﹤0.01%
1,244
LYB icon
425
LyondellBasell Industries
LYB
$19.5B
$47K ﹤0.01%
631

Similar funds

Fred Alger Management's Q2 2016 Portfolio in Review

As of Q2 2016, Fred Alger Management held 598 positions worth $18.9B, down 4.1% from $19.7B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Fred Alger Management withdrew a net $821M in Q2 2016, closing 77 positions and reducing 267 holdings. Its most notable exit was JARDEN CORPORATION, an estimated $258M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 19% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Fred Alger Management opened a new position in TJX Companies worth $43.2M.

  • Fred Alger Management's largest Q2 2016 buy was TJX Companies: 1,117,850 shares worth $43.2M.
  • Fred Alger Management added most to Amazon in Q2 2016, an estimated $149M increase.
  • Fred Alger Management's biggest Q2 2016 reduction was McDonald's, cutting an estimated $149M.
  • Fred Alger Management fully exited JARDEN CORPORATION in Q2 2016, selling an estimated $258M.
  • Fred Alger Management's ten largest holdings make up 36% of its $18.9B portfolio in Q2 2016.
  • Fred Alger Management opened 47 new positions and closed 77 in Q2 2016.
  • Fred Alger Management's portfolio value fell 4.1% quarter-over-quarter to $18.9B.

Based on Fred Alger Management's 13F filing for Q2 2016, filed 15 Aug 2016.